ARCT EBITDA Growth
Arcturus Therapeutics Holdings Inc · EBITDA Growth
ARCT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-44.16%period ending
ARCT TTM EBITDA YoY % (-1326.12% → -44.16%)
Year-over-year change
High-resolution chart · PNG
ARCT ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -44.1598% | |
| -3.6803% | |
| 29.5917% | |
| -8.007% | |
| 14.9605% | |
| 36.0775% | |
| -220.2847% | |
| -155.2747% | |
| -177.2792% | |
| -186.6573% | |
| -259.2803% | |
| 174.7199% | |
| 153.7862% | |
| 160.4385% | |
| 107.5231% | |
| 26.8856% | |
| 0.5513% | |
| -63.9986% | |
| -185.6342% | |
| -268.6242% | |
| -311.7971% | |
| -301.9484% | |
| -164.6364% | |
| -276.9774% | |
| -256.6582% | |
| -40.2795% | |
| -27.1142% | |
| 32.0293% | |
| 41.1583% | |
| -114.1163% | |
| -212.0345% | |
| -63.9029% | |
| -3.5583% | |
| 57.4174% | |
| 73.0185% | |
| 47.5364% | |
| 11.0149% | |
| -17.4369% | |
| -26.8767% | |
| -12.7515% | |
| 25.9929% | |
| 34.9555% | |
| 40.1274% | |
| 33.2392% | |
| -12.7687% | |
| -69.7213% | |
| -219.1791% | |
| -551.9845% | |
| -1,112.2581% | |
| -1,326.1218% |